Stevanato Group Corp (STVN): Rasio kapitalisasi pasar marang pendapatan

Simbol lan logo merek Stevanato (STVN)

Stevanato Group S.p.A. (STVN) dominates the precision glass segment for complex drugs. The Italian brand blends a family-run approach with stringent pharmaceutical regulations. Patent protection and an extensive infrastructure enable the company to maintain high profitability. The P/S multiple trend illustrates the correlation between market capitalization and revenue, while 0.50 shows the current value of the metric at this stage.

Rasio rega marang pendapatan: Stevanato Group (STVN) kanggo 04.07.2022 - 13.11.2026

Rincian metrik lan analitis perusahaan Stevanato (STVN)

- kuotasi lan prakiraan analis:
Ringkesan analitik perusahaan:stevanatogroup.com
Produk seri stevanatogroup.com

To identify undervalued assets, it is essential for an investor to compare market capitalization with sales volume to determine the fair value of a business relative to its revenue. Analyzing this ratio helps identify the risk of overpayment during revenue declines, which is particularly relevant for Stevanato Group S.p.A. (STVN) during the costly electrification of furnaces; therefore, the boundaries of a sustainable valuation corridor should be monitored via the P/S chart.

Pesaing Stevanato Group S.p.A.

Kapitalisasi marang volume dodolan ISRG|Rasio rega marang pendapatan Danaher DHR|Rasio kapitalisasi pasar marang pendapatan BDX|STE: Kapitalisasi marang pendapatan|WST - Multiplikator P/S|Baxter International (BAX) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan masimo.com|TFX (Teleflex) - Multiplikator P/S|Rega marang dodolan Merit Medical Systems, Inc. MMSI|Rasio rega marang pendapatan Envista Holdings Corp (NVST)|ICU Medical Inc. - Rasio kapitalisasi marang pendapatan|DENTSPLY SIRONA Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan LMAT (lemaitre.com)|ATRC - Rasio rega marang pendapatan|Koefisien rega marang pendapatan STAAR Surgical Co. STAA|ChromaDex Corp (NAGE) - Rasio rega marang pendapatan|ZIMV - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan ANGO|CERS (cerus.com) - Kapitalisasi marang volume dodolan|Multiplikator P/S TKNO|MGRM - Rega marang dodolan|Sharps Technology - Kapitalisasi marang pendapatan|InfuSystem - Rasio rega marang pendapatan|Utah Medical Products - Multiplikator P/S|KRMD - Multiplikator P/S|Nyxoah (NYXH) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan MBOT|PDEX (Pro-Dex Corp) - Multiplikator P/S|Multiplikator P/S Zentek Corp|Kapitalisasi marang pendapatan ELUT (Elutia Inc.)|Kapitalisasi marang volume dodolan MLSS|Rasio rega marang pendapatan NEXGEL NXGL|Retractable Technologies Inc. (RVP) - Rega marang dodolan|HBIO: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan FEMY (Femasys Corporation)|MHUA: Multiplikator P/S|Multiplikator rega marang pendapatan Predictive Oncology Inc. POAI|Rasio rega marang pendapatan Callan JMB Inc.|ATRI: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan NeuroMetrix Corp (NURO)